INO
Inovio Pharmaceuticals Inc
1.30$
+4.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 462.4% | 142.4% | 250.8% | 233.5% | 312.5% | 2,140.5% | 1,271.7% | 266.6% | 53.6% | 421.1% | 1,437.4% | 4,574.1% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -1,337.4% | 100.0% | |
| 326.1% | 142.4% | 250.8% | 233.5% | 312.5% | 2,140.5% | 1,271.7% | 14,043.6% | 1,828.5% | 10,417.7% | 34,727.1% | 82,957.4% | |
| 151.7% | 44.5% | 67.6% | 67.0% | 96.2% | 661.6% | 502.6% | 3,028.7% | 878.8% | 5,718.9% | 16,989,813.4% | 50,013.9% | |
| 477.7% | 187.0% | 318.4% | 300.5% | 408.7% | 2,802.1% | 1,774.2% | 17,072.3% | 2,707.4% | 17,400.3% | 51,014.3% | 132,971.3% | |
| -377.7% | -84.5% | -215.5% | -198.1% | -308.7% | -2,702.1% | -1,674.2% | -16,972.3% | -2,607.4% | -17,300.3% | -51,616.9% | -132,871.3% | |
| 32.1% | 12.8% | 0.4% | 0.1% | 1.1% | 193.3% | 117.4% | 109.1% | 12.2% | 147.0% | 81.7% | 0.0% | |
| -345.6% | -76.9% | -208.5% | -208.9% | -311.0% | -2,938.0% | -2,259.7% | -17,109.9% | -2,726.7% | -16,239.9% | -49,254.3% | -130,000.0% | |
| -35.6% | -5.2% | -13.1% | 4.2% | 7.1% | -6.3% | 704.3% | 24.5% | 21.1% | 0.0% | -49,205,014.7% | – | |
| -345.4% | -71.9% | -208.5% | -208.9% | -318.1% | -2,902.8% | -2,245.4% | -17,109.9% | -2,726.7% | -16,239.9% | -49,254.3% | -130,000.0% | |
| -362.7% | -82.2% | -209.7% | -200.7% | -294.6% | -2,610.6% | -2,018.0% | -16,709.7% | -2,639.8% | -15,671.8% | -47,735.2% | -125,425.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.